🇺🇸 FDA
Patent

US 8034768

Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

granted A61KA61K38/12A61P

Quick answer

US patent 8034768 (Composition and method for the treatment of diseases affected by histone deacetylase inhibitors) held by The Board of Regents of the University of Texas System expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/12, A61P, A61P35/00